DNA-powered therapy halves 'bad' cholesterol, bypassing statins

TL;DR
A DNA-based treatment using polypurine hairpins to silence PCSK9 lowers LDL cholesterol and boosts LDL receptors. In liver cells HpE9/HpE12 reduced PCSK9 RNA by up to 74% and protein by up to 87%; in transgenic mice a single injection cut PCSK9 by ~50% and cholesterol by ~47% within days, potentially offering a statin-free alternative with fewer side effects.
Topics:healthhealth-and-medicine#health-and-medicine#ldl-cholesterol#ldl-receptor#pcsk9#polypurine-hairpins#statins
Want the full story? Read the original reporting
Read on ScienceDaily